US proposal to halve biosimilar development costs for India's Biocon, top exec says
India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more
November 13, 2025
Missing State Senate candidate from western Oklahoma found dead: What we know
Catholic priest who criticized Trump immigration crackdown named West Virginia bishop
The Taylor Frankie Paul saga puts a spotlight on reality TV’s love of influencers
Trump task force report alleges anti-Christian discrimination under Biden administration
Former US congressman convicted of secretly lobbying for Venezuela
WHO delays pandemic treaty amid pathogen-sharing dispute
Colombia-Ecuador trade collapsing as tariff war intensifies, business groups say
Saudi oil prince's iron grip faces ultimate test with UAE's shock OPEC exit
The ride continues for Alex Fitzpatrick, who's in the mix at Doral's Cadillac Championship